loading
前日終値:
$0.3859
開ける:
$0.38
24時間の取引高:
374.38K
Relative Volume:
0.75
時価総額:
$10.24M
収益:
$16.77M
当期純損益:
$-11.87M
株価収益率:
-0.5551
EPS:
-0.626
ネットキャッシュフロー:
$-5.90M
1週間 パフォーマンス:
-24.37%
1か月 パフォーマンス:
-35.01%
6か月 パフォーマンス:
-69.17%
1年 パフォーマンス:
-73.04%
1日の値動き範囲:
Value
$0.3248
$0.415
1週間の範囲:
Value
$0.3248
$0.4765
52週間の値動き範囲:
Value
$0.3248
$2.60

Immunoprecise Antibodies Ltd Stock (IPA) Company Profile

Name
名前
Immunoprecise Antibodies Ltd
Name
セクター
Healthcare (1195)
Name
電話
-
Name
住所
-
Name
職員
101
Name
Twitter
Name
次回の収益日
2024-09-16
Name
最新のSEC提出書
Name
IPA's Discussions on Twitter

IPA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
IPA 0.346 10.24M 16.77M -11.87M -5.90M -0.626
VRTX 449.87 115.43B 10.63B -479.80M -1.35B 13.33
REGN 745.58 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 595.99 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.18 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.15 24.89B 3.30B -501.07M 1.03B 11.54

Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-12-02 開始されました H.C. Wainwright Buy
2021-10-25 開始されました The Benchmark Company Buy

Immunoprecise Antibodies Ltd (IPA) 最新ニュース

pulisher
Nov 13, 2024

ImmunoPrecise's Breakthrough Cancer Treatment Shows Promise in $20.7B ADC Market | IPA Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 13, 2024

Immunoprecise Antibodies Ltd (IPA-Q) QuotePress Release - The Globe and Mail

Nov 13, 2024
pulisher
Nov 05, 2024

ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation - BioSpace

Nov 05, 2024
pulisher
Oct 28, 2024

ImmunoPrecise Pummeled Despite Advancing Anti-Aging Research with Mayo - Baystreet.ca

Oct 28, 2024
pulisher
Oct 28, 2024

ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology - Business Wire

Oct 28, 2024
pulisher
Oct 24, 2024

ImmunoPrecise Antibodies Announces Annual Meeting Plans - TipRanks

Oct 24, 2024
pulisher
Oct 21, 2024

ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024 - BioSpace

Oct 21, 2024
pulisher
Oct 21, 2024

ImmunoPrecise touts potential of rabbit monoclonal antibodies in oncology - Pharmaceutical Technology

Oct 21, 2024
pulisher
Oct 21, 2024

ImmunoPrecise Antibodies to Join AI Drug Summit - TipRanks

Oct 21, 2024
pulisher
Oct 11, 2024

ImmunoPrecise Sets Virtual AGM for November 2024 - TipRanks

Oct 11, 2024
pulisher
Oct 10, 2024

ImmunoPrecise Heralds Nobel Win, AI-Driven Biotherapeutics - TipRanks

Oct 10, 2024
pulisher
Oct 10, 2024

ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design - Business Wire

Oct 10, 2024
pulisher
Oct 09, 2024

ImmunoPrecise Antibodies Ltd (IPA) Q4 2024 Earnings Call Highlights: Record Revenue Growth Amid ... - Yahoo Finance

Oct 09, 2024
pulisher
Oct 07, 2024

Financial Metrics Exploration: Understanding ImmunoPrecise Antibodies Ltd (IPA) Through Ratios - The Dwinnex

Oct 07, 2024
pulisher
Oct 07, 2024

ImmunoPrecise Antibodies Ltd (IPA) Stock: A Year of Market Fluctuations - The InvestChronicle

Oct 07, 2024
pulisher
Oct 03, 2024

Take off with ImmunoPrecise Antibodies Ltd (IPA): Get ready for trading - SETE News

Oct 03, 2024
pulisher
Oct 03, 2024

ImmunoPrecise and Biotheus partner on bispecific antibodies to treat cancer - Yahoo Finance

Oct 03, 2024
pulisher
Oct 02, 2024

ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus - BioSpace

Oct 02, 2024
pulisher
Oct 02, 2024

ImmunoPrecise Advances Cancer Therapy with Biotheus Partnership - TipRanks

Oct 02, 2024
pulisher
Oct 01, 2024

Have you been able to find a good deal on ImmunoPrecise Antibodies Ltd’s shares? - US Post News

Oct 01, 2024
pulisher
Oct 01, 2024

ImmunoPrecise Antibodies Ltd (IPA)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

Oct 01, 2024
pulisher
Sep 26, 2024

ImmunoPrecise’s Breakthroughs in Cancer Antibody Therapies - TipRanks

Sep 26, 2024
pulisher
Sep 26, 2024

ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments - StockTitan

Sep 26, 2024
pulisher
Sep 23, 2024

ImmunoPrecise Sets Virtual Annual General Meeting - TipRanks

Sep 23, 2024
pulisher
Sep 23, 2024

Ratio Review: Analyzing ImmunoPrecise Antibodies Ltd (IPA)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Was ImmunoPrecise Antibodies Ltd (IPA)’s session last reading good? - US Post News

Sep 23, 2024
pulisher
Sep 18, 2024

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2025 Earnings Call Transcript - Insider Monkey

Sep 18, 2024
pulisher
Sep 18, 2024

ImmunoPrecise Unveils Executive Compensation Strategy - TipRanks

Sep 18, 2024
pulisher
Sep 17, 2024

IPA Stock Update: ImmunoPrecise Antibodies Ltd’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle

Sep 17, 2024
pulisher
Sep 17, 2024

Earnings call: ImmunoPrecise announces mixed Q1 results, eyes future growth - Investing.com Australia

Sep 17, 2024
pulisher
Sep 17, 2024

Post-Trade Analysis: ImmunoPrecise Antibodies Ltd (IPA) Slides -19.12, Closing at 0.54 - The Dwinnex

Sep 17, 2024
pulisher
Sep 17, 2024

ImmunoPrecise Antibodies Ltd (IPA) Q1 2025 Earnings Call Transcript Highlights: Revenue Growth ... - Yahoo Finance UK

Sep 17, 2024
pulisher
Sep 17, 2024

ImmunoPrecise Antibodies Ltd (IPA) Q1 2025 Earnings Call Transcript Highlights: Revenue Growth ... By GuruFocus - Investing.com Canada

Sep 17, 2024
pulisher
Sep 16, 2024

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q1 Loss, Misses Revenue Estimates - MSN

Sep 16, 2024
pulisher
Sep 16, 2024

ImmunoPrecise Achieves AI-Driven Growth Amidst Challenges - TipRanks

Sep 16, 2024
pulisher
Sep 16, 2024

ImmunoPrecise Advances Biotherapeutic Research Efficiency - TipRanks

Sep 16, 2024
pulisher
Sep 16, 2024

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 - Business Wire

Sep 16, 2024
pulisher
Sep 13, 2024

Earnings To Watch: ImmunoPrecise Antibodies Ltd (IPA) Reports Q1 2025 Result - GuruFocus.com

Sep 13, 2024
pulisher
Sep 09, 2024

ImmunoPrecise Announces Upcoming Earnings Call - TipRanks

Sep 09, 2024
pulisher
Sep 09, 2024

IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 on September 16, 2024 - Business Wire

Sep 09, 2024
pulisher
Aug 26, 2024

ImmunoPrecise Joins Prestigious Global Investment Conference - TipRanks

Aug 26, 2024
pulisher
Aug 26, 2024

ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York - Business Wire

Aug 26, 2024
pulisher
Aug 23, 2024

ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements - StockTitan

Aug 23, 2024
pulisher
Aug 19, 2024

ImmunoPrecise Antibodies Successfully Engineers in silico Antibodies to Elusive Tumor Protein Using Its Patented LENSai Technology - Chronicle-Tribune

Aug 19, 2024
pulisher
Aug 17, 2024

Short Interest in ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Declines By 14.4% - Defense World

Aug 17, 2024
pulisher
Aug 16, 2024

Benchmark Lowers ImmunoPrecise Antibodies (NASDAQ:IPA) Price Target to $3.00 - Defense World

Aug 16, 2024
pulisher
Aug 14, 2024

Immunoprecise shares target cut, rating held on market volatility - Investing.com

Aug 14, 2024

Immunoprecise Antibodies Ltd (IPA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):